Evaluating The Antitumor Activity Of MEDI-522 With Or Without Dacarbazine In Patients With Metastatic Melanoma

NCT00066196 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Malignant Metastatic Melanoma

Interventions

BIOLOGICAL: MEDI--522
BIOLOGICAL: Integrin + Dacarbazine

Sponsor

MedImmune LLC